Antibe Therapeutics Inc.
ATE
Kedudukan dalam Saham
#31912
Antibe Therapeutics Inc. is a biotechnology company specializing in the... Antibe Therapeutics Inc. is a biotechnology company specializing in the development of groundbreaking therapeutics and medical devices. Operating internationally, including Canada, Europe, and the United States, their work targets pain, inflammation, and regenerative medicine. A key focus is developing drugs designed to prevent the gastrointestinal harm and bleeding often caused by non-steroidal anti-inflammatory drugs. Their leading candidate, Otenaproxesul, is a hydrogen sulfide-releasing derivative of naproxen. This compound has already finished a Phase 2B gastrointestinal safety study and is being investigated for a range of indications, such as post-operative pain, migraines, dysmenorrhea, traumatic injuries, dental pain, and gout. Additionally, their product portfolio features ATB-352, currently in preclinical development for managing acute pain. The company, incorporated in 2009, is headquartered in Toronto, Canada.
Harga Saham
$0.21483059
Disegerakkan terakhir: 2024-05-07
Modal Pasaran
$11.13M
Perubahan (1 hari)
0.34%
Perubahan (1 tahun)
-0.36%
Negara
CA
Perdagangan Antibe Therapeutics Inc. (ATE)
Kategori
Healthcare
Sejarah dividen untuk Antibe Therapeutics Inc. (ATE)
Antibe Therapeutics Inc. (simbol saham: ATE) telah membuat sejumlah 0 pembayaran dividen.
Jumlah semua dividen (disesuaikan untuk pemecahan saham): 0.00
Hasil dividen (TTM): 0
Jumlah semua dividen (disesuaikan untuk pemecahan saham): 0.00
Hasil dividen (TTM): 0
Pembayaran dividen untuk Antibe Therapeutics Inc. (ATE) dari 2026 hingga 2026
Pembayaran dividen tahunan
| Tahun | Dividen (diselaraskan untuk pemecahan saham) | Ubah |
|---|---|---|
| Tidak cukup data untuk tarikh yang disediakan. | ||
Senarai semua pembayaran dividen
| Tahun | Dividen | Ubah |
|---|---|---|
| Tidak cukup data untuk tarikh yang disediakan. | ||
Pembayaran dividen untuk syarikat serupa atau pesaing
| Syarikat | Jumlah pembayaran dividen | Negara |
|---|---|---|
| 173.00% |
US
|
|
| 178.00% |
IE
|
|
| 85.00% |
US
|
|
| 0.00% |
US
|
|
| 0.00% |
DE
|
